An investigation into a fraudulent cancer breakthrough, a test for the future president of MIT, and a new age of doubt in science.
Kornbluth responded to a report detailing her time as an administrator at Duke amid a cancer research scandal more than a decade ago.
How Trump and DOGE reshaped the NIH: delayed funds, canceled projects, and scientists scrambling to save research as billions in grants stall
A modified CD40 antibody shrank or eliminated tumors in six of 12 metastatic cancer patients without the side effects that plagued earlier CD40 studies.
